Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FOUND: Optumrx - What They Never Told You

Pharmacy tells young man his inhaler now costs $500, so he buys a cheaper solution. Days later, he’s found dead clutching it

$539 stood between him and his next breath.

We Got This Covered

Grieving parents couldn’t understand how their son died of an asthma attack. Then they found out how much his meds now cost

EXCLUSIVE: Shanon and Bill Schmidtknecht tell Rhian Lubin of their grief for son Cole and their fight for a fairer health insurance system

The Independent UK

Couple sues Walgreens and Optum Rx over son’s death after $500 price rise for asthma meds

A Wisconsin couple is suing Walgreens and a pharmacy benefits company alleging their son died because he couldn't afford a sudden $500 jump in the cost of his asthma medication

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

What are pharmacy benefit managers? A health economist explains how lack of competition drives up drug prices for everyone

Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic conditions that afflict millions of Americans. But while everyone agrees these drugs have the potential to transform lives, no one can agree on how best to pay for them.

The Conversation

Kentucky attorney general targets another big pharmacy benefit manager in opioid-related lawsuit

Kentucky’s attorney general has expanded an opioid-related lawsuit to target another pharmacy benefit manager

The Independent UK

Stocks Settle Higher on Q1 Earnings Optimism

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.87%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.02%. US stock indexes settled moderately higher on Monday, with the Dow Jones Industrials posting...

Barchart

Stocks Soar with Earnings on Tap

The S&P 500 Index ($SPX ) (SPY ) is up +1.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.53%. US stock indexes today are surging higher. Reduced geopolitical tensions are positive for stocks after...

Barchart

Read news from The Economist, FT, and more,
with one subscription

Stocks Mixed with Earnings on Tap

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.04%. US stock indexes today are mixed. Reduced geopolitical tensions are positive for stocks...

Barchart

Stocks Push Higher Ahead of Megacap Tech Earnings

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.42%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.57%. US stock indexes are moderately higher today as geopolitical tensions ease from the...

Barchart

This Essential Medical Treatment Could Finally Become Affordable For Everyone

Pharmaceutical giant Eli Lilly is slashing the list prices for some of its most popular insulin products by 70 percent.

Inverse

Eli Lilly is cutting insulin prices and capping copays at $35 – 5 questions answered

Pharmaceutical giant Eli Lilly is slashing the list prices for some of its most popular insulin products by 70% and capping insulin copays at US$35 for uninsured patients and those with private health insurance. These changes follow efforts by the federal government, the California state government, nonprofits and some companies…

The Conversation

Drug company middlemen likely to be a focus in 118th Congress

WASHINGTON — Factions of the health care system and members of Congress are turning their fire on an oft-maligned part of the drug pricing system — the middlemen who negotiate discounts with drug companies on behalf of health plans.

Tribune News Service

Drug company middlemen likely to be a focus in 118th Congress - Roll Call

PBMs argue that the rebates they collect from drug companies in exchange for coverage by a health plan are used to lower premiums.

Roll Call

Drugmakers sued over insulin prices

California's Attorney General Rob Bonta sued the six major companies that dominate the U.S. insulin market

Salon

Get all your
news in one place.

100's of premium titles.
One news app.

Chicago Tribune

Want free, at-home COVID-19 tests from pharmacies and insurers? It’s not always easy, despite requirements

CHICAGO -- Some Illinois residents say they’re still having trouble getting free at-home COVID-19 tests from pharmacies and insurance companies, more than three months after the White House began requiring insurers to cover them.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.